← EU Feed

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc

AI Briefing

  • Roche reports 6% sales growth at constant exchange rates in Q1 2026
  • Sales growth of -5% in CHF due to Swiss franc appreciation
  • Roche CEO Thomas Schinecker attributes strong start to the year to sales growth
Advertisement
Read Original Article